T1	Intervention 1129 1319	A sample of 14 participants with ASD and 14 matched controls participated in two study sessions in which propranolol and placebo were administered in a counterbalanced, double-blinded manner
T2	Intervention 781 1121	The present pilot study sought to explore the effects of pharmacological intervention via propranolol, a nonselective Î²-adrenergic antagonist and known anxiolytic, on facial scanning in ASD. Specifically, we wished to determine whether there is an increase in eye contact and a decrease in mouth fixation with administration of propranolol.
